Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock

Motti Sapir1.33K FollowersFollow5ShareSavePlay(9min)Comment(1)SummaryClover Health is positioned for a major turnaround, with operations and profitability metrics improving sharply despite market skepticism.CLOV projects 46% membership growth and 49% revenue growth for 2026, guiding toward its first full year of positive GAAP net income.Operating leverage is materializing as SG&A improves, member retention exceeds 95%, and mature cohorts deliver over $200 monthly profit per member.Valuation remains deeply discounted at <0.5x 2026 revenue and 3.3x book, while risks hinge on execution, star ratings, and regulatory stability. pada smith/iStock via Getty Images Clover Health (CLOV) has ended up in a pretty unusual spot in Medicare Advantage. Most folks still doubt it, but looking at what’s actually happened lately, that skepticism doesn’t really hold up. Last time I looked atThis article was written byMotti Sapir1.33K FollowersFollowWith over 15 years of experience in the markets and a degree in economics, I focus on breaking down companies with clarity and discipline. My goal is to give individual investors a straightforward, honest view—what’s working, what isn’t, and where the risks and opportunities actually are. I don’t chase narratives. I follow the numbers and the business underneath.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.